文献速递眼底病与葡萄膜炎

中国东北地区人群中糖尿病视网膜病变的发病率、进展与消退

Incidence, progression and regression of diabetic retinopathy in a northeastern Chinese population.
PubMed 文献 · Br J Ophthalmol · 2022-07-19

研究纳入1392例完成基线和随访眼底照相的2型糖尿病患者,平均间隔21.2个月,年龄性别标准化后的糖尿病视网膜病变发病率为5.8%、进展率为26.8%、消退率为10.0%。除血糖控制不佳外,视网膜中央静脉等效直径较宽与发病和进展相关,未接受胰岛素治疗和视网膜中央动脉等效直径较宽与消退相关。

要点

  • 年龄性别标准化发病率5.8%(95%CI 4.7%至6.9%),进展率26.8%(95%CI 24.8%至28.8%),消退率10.0%(95%CI 8.6%至11.3%)。
  • 视网膜中央静脉等效直径≥250 µm vs <210 µm与发病相关(RR 2.17,95%CI 1.09至4.32)及进展相关(RR 2.00,95%CI 1.02至3.96)。
  • 未接受胰岛素治疗(RR 0.64,95%CI 0.43至0.97)和视网膜中央动脉等效直径每增加10 µm(RR 1.14,95%CI 1.02至1.26)与病变消退相关。

核心结论

  • 研究确定了中国东北地区2型糖尿病患者的糖尿病视网膜病变发病率、进展率和消退率,视网膜血管直径除血糖水平外也影响糖尿病视网膜病变的自然演变。

研究设计与样本

  • 研究纳入2006例于2012—2013年完成基线检查并在平均21.2个月后接受复查的患者,其中1392例基线和随访眼底照片均可分级者被纳入分析。
  • 发病定义为基线无糖尿病视网膜病变的患者新发任何糖尿病视网膜病变,进展定义为基线有病变的眼按双眼Early Treatment Diabetic Retinopathy Study级别拼接后增加≥2级,消退定义为减少≥2级。

主要发现

  • 年龄和性别标准化的发病率、进展率和消退率分别为5.8%(95%CI 4.7%至6.9%)、26.8%(95%CI 24.8%至28.8%)和10.0%(95%CI 8.6%至11.3%)。
  • 除血糖控制不佳外,视网膜中央静脉等效直径≥250 µm vs <210 µm与发病相关(RR 2.17,95%CI 1.09至4.32)及进展相关(RR 2.00,95%CI 1.02至3.96)。
  • 未接受胰岛素治疗的患者(RR 0.64,95%CI 0.43至0.97)和视网膜中央动脉等效直径较宽的患者(每增加10 µm,RR 1.14,95%CI 1.02至1.26)可能表现出糖尿病视网膜病变消退。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To determine the incidence, progression and regression of diabetic retinopathy (DR), with corresponding risk factors, in a northeastern Chinese population of patients with type 2 diabetes. METHODS: Among 2006 patients who completed baseline examinations in 2012-2013 and underwent re-examination after a mean interval of 21.2 months, 1392 patients with gradable fundus photographs for both baseline and follow-up examinations were included. Incidence was defined as new development of any DR among patients without DR at baseline. An increase of ≥2 scales (concatenating Early Treatment Diabetic Retinopathy Study levels of both eyes) in eyes with DR at baseline was defined as progression, while a reduction of ≥2 scales was defined as regression. RESULTS: The age- and sex-standardised incidence, progression and regression were 5.8% (95% CI 4.7% to 6.9%), 26.8% (95% CI 24.8% to 28.8%) and 10.0% (95% CI 8.6% to 11.3%), respectively. In addition to poor blood glucose control, wider central retinal venular equivalent was associated with both incidence (relative risk (RR) 2.17, 95% CI 1.09 to 4.32, for ≥250 µm vs <210 µm) and progression (RR 2.00, 95% CI 1.02 to 3.96, for ≥250 µm vs <210 µm). Patients without insulin therapy (RR 0.64, 95% CI 0.43 to 0.97) and patients with wider central retinal arteriolar equivalent (RR 1.14, 95% CI 1.02 to 1.26, per 10 µm increase) were likely to exhibit DR regression. CONCLUSION: We determined the incidence, progression and regression of DR among northeastern Chinese patients with type 2 diabetes. Retinal vessel diameters, in addition to blood glucose level, influence the natural evolution of DR.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Lin Z, Wen L, Wang Y, et al. Incidence, progression and regression of diabetic retinopathy in a northeastern Chinese population. Br J Ophthalmol. 2022. PMID: 35864776. doi:10.1136/bjo-2022-321384

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。